As previously reported in the Current Report on Form 8-K filed by TRxADE HEALTH, Inc. with the Securities and Exchange Commission (the Commission"), on March 3, 2023, Ms. Janet Huffman, the then Chief Financial Officer of the Company, effective March 1, 2023, transitioned from Chief Financial Officer to Acting Chief Financial Officer. On March 6, 2023, Ms. Huffman resigned as Acting Chief Financial Officer of the Company in order to transition to a full-time role with another employer, and not due to any disagreement relating to the Company's operations, policies or procedures, provided that Ms. Huffman will continue to provide consulting services to the Company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
17.65 USD | -4.54% |
|
+48.95% | +239.66% |
06-26 | Tranche Update on TRxADE HEALTH, Inc.'s Equity Buyback Plan announced on May 28, 2021. | CI |
06-26 | TRxADE HEALTH, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+239.66% | 26M | |
+29.22% | 435B | |
+40.18% | 293B | |
+15.80% | 148B | |
+12.23% | 97.98B | |
+23.42% | 86.61B | |
+67.53% | 62.81B | |
+8.83% | 43.94B | |
+11.73% | 32.79B | |
-15.52% | 30.32B |
- Stock Market
- Equities
- MEDS Stock
- News TRxADE HEALTH, Inc.
- TRxADE HEALTH, Inc. Announces Resignation of Janet Huffman as Acting Chief Financial Officer